دورية أكاديمية

Challenges in translating end points from trials to observational cohort studies in oncology

التفاصيل البيبلوغرافية
العنوان: Challenges in translating end points from trials to observational cohort studies in oncology
المؤلفون: Ording AG, Cronin-Fenton D, Ehrenstein V, Lash TL, Acquavella J, Rørth M, Sørensen HT
المصدر: Clinical Epidemiology, Vol 2016, Iss Issue 1, Pp 195-200 (2016)
بيانات النشر: Dove Medical Press, 2016.
سنة النشر: 2016
المجموعة: LCC:Infectious and parasitic diseases
مصطلحات موضوعية: Endpoint determination, medical oncology, treatment outcome, neoplasms, research design., Infectious and parasitic diseases, RC109-216
الوصف: Anne Gulbech Ording,1 Deirdre Cronin-Fenton,1 Vera Ehrenstein,1 Timothy L Lash,1,2 John Acquavella,1 Mikael Rørth,1 Henrik Toft Sørensen1 1Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; 2Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA Abstract: Clinical trials are considered the gold standard for examining drug efficacy and for approval of new drugs. Medical databases and population surveillance registries are valuable resources for post-approval observational research, which are increasingly used in studies of benefits and risk of new cancer drugs. Here, we address the challenges in translating endpoints from oncology trials to observational studies. Registry-based cohort studies can investigate real-world safety issues – including previously unrecognized concerns – by examining rare endpoints or multiple endpoints at once. In contrast to clinical trials, observational cohort studies typically do not exclude real-world patients from clinical practice, such as old and frail patients with comorbidity. The observational cohort study complements the clinical trial by examining the effectiveness of interventions applied in clinical practice and by providing evidence on long-term clinical outcomes, which are often not feasible to study in a clinical trial. Various endpoints can be included in clinical trials, such as hard endpoints, soft endpoints, surrogate endpoints, and patient-reported endpoints. Each endpoint has it strengths and limitations for use in research studies. Endpoints used in oncology trials are often not applicable in observational cohort studies which are limited by the setting of standard clinical practice and by non-standardized endpoint determination. Observational studies can be more helpful moving research forward if they restrict focus to appropriate and valid endpoints. Keywords: endpoint determination, medical oncology, treatment outcome, neoplasms, research design
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1179-1349
Relation: https://www.dovepress.com/challenges-in-translating-end-points-from-trials-to-observational-coho-peer-reviewed-article-CLEP; https://doaj.org/toc/1179-1349
URL الوصول: https://doaj.org/article/792c2ee511af4ba58dcac55a57636665
رقم الأكسشن: edsdoj.792c2ee511af4ba58dcac55a57636665
قاعدة البيانات: Directory of Open Access Journals